Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major facilitator superfamily domain-containing protein 1 (MFSD1) is an atypical solute carrier of the major facilitator superfamily, primarily localized in lysosomal membranes. MFSD1 forms a stable complex with the accessory protein GLMP and acts as a selective uniporter for dipeptides containing lysine, arginine, or histidine. It facilitates export of dipeptides produced via lysosomal proteolysis into the cytoplasm, providing an alternative route for metabolic recycling and biosynthetic precursors when amino acid exporters are saturated. MFSD1 works independently of the lysosomal pH gradient, is specific for dipeptides, and is structurally distinct from canonical proton-coupled oligopeptide transporters. It is ubiquitously expressed and plays essential roles in liver homeostasis, cell migration, integrin recycling, and possibly immune cell development. Disruption of MFSD1 results in severe metabolic, hepatic, immunological, and proliferative abnormalities, highlighting its clinical relevance as a potential therapeutic and research target[1][2][3][4][5][6][7][8][9][10].
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major facilitator superfamily domain-containing protein 1 (MFSD1).